Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
Top Cited Papers
Open Access
- 15 September 2008
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 112 (6) , 2261-2271
- https://doi.org/10.1182/blood-2007-12-128843
Abstract
Adoptive immunotherapy with T cells expressing a tumor-specific chimeric T-cell receptor is a promising approach to cancer therapy that has not previKeywords
This publication has 41 references indexed in Scilit:
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primatesJournal of Clinical Investigation, 2008
- Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with NeuroblastomaMolecular Therapy, 2007
- Donor leukocyte infusions in myeloid malignancies: new strategiesBest Practice & Research Clinical Haematology, 2006
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- CD8+ T‐cell memory in tumor immunology and immunotherapyImmunological Reviews, 2006
- Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphomaBlood, 2004
- Nonablative Allogeneic Stem-Cell Transplantation for Advanced/Recurrent Mantle-Cell LymphomaJournal of Clinical Oncology, 2003
- Interleukin (IL)-15 and IL-7 Jointly Regulate Homeostatic Proliferation of Memory Phenotype CD8+ Cells but Are Not Required for Memory Phenotype CD4+ CellsThe Journal of Experimental Medicine, 2002
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivityNature, 1979